The analyst cut her price target on MRNA to $51 from $99 ... which MRNA is developing in partnership with Merck (MRK), to lift MRNA stock this year. Ellison’s Statement on Potential Cancer ...

Moderna (NASDAQ:MRNA – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Friday, February 14th. Analysts expect the company to announce earnings of ($2.

There's always some hope that a struggling stock can turn things around, but three that I wouldn't count on doing that are Tilray Brands (NASDAQ: TLRY), Moderna (NASDAQ: MRNA), and Plug Power ...

Martin shared that strategists have been putting out their target price for the S&P 500 ... If you are looking for an AI stock that is more promising than MRNA but that trades at less than 5 ...

If an investor was to purchase shares of MRNA stock at the current price level of $37.60/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

The analyst cut her price target on MRNA to $51 from $99 ... But she does not expect the jab, which MRNA is developing in partnership with Merck (MRK), to lift MRNA stock this year. Ellison's ...